Starpharma Holdings Limited

A$0.45As of Sun 8 Nov 2026, 12:00 UTC
ASX:SPLHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR (4.57%)
Div yield —
ROE (45.55%)
Biotechnology
Beta (5Y) 0.83
PE TTM —
TSR TTM 33.37%
Mkt cap A$213.5M
ROIC (26.00%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.472
6.06%
(92.97%)
Hold 4|4|7|4|6
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.01
0.01
0.01
0.01
20.15%
19.04%
20.43%
11.13%
Revenue$M
17.03
17.19
17.48
17.10
11.88%
10.04%
7.35%
(0.67%)
Peers (US$146.6M)
Cap (US$)
PE
145.5M
13.73x
Capital
TTM
5Y
10Y
Leveragex
0.602
0.026
0.028
EBIT/Intx
0.868
0.123
0.142
Own earn%
473.27
(11.56)
(7.26)
Sh yield%
48.58
37.76
35.54
Owners
Insiders/Inst%
12.89
64.84
Short interest%
2.35
SBC / revenue%
5.44
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
1–15
$1 testx
—
Incr. ROIC%
17